https://ntp.niehs.nih.gov/go/6129

TDMS Study 89002-02 Pathology Tables

NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97
Route: DOSED FEED                                                                                                 Time: 08:30:28
                                                          27 WEEK SSAC
       Facility:  Battelle Columbus Laboratory
       Chemical CAS #:  87-86-5
       Lock Date:  07/13/95
       Cage Range:  All
       Reasons For Removal:    25017 Scheduled Sacrifice
       Removal Date Range:     All
       Treatment Groups:       Include 002    0 PPM
                               Include 010    1000 PPM
                               Include 001    0 PPM
                               Include 009    1000 PPM
a  Number of animals examined microscopically at site and number of animals with lesion
                                                              Page   1
NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97  
Route: DOSED FEED                                                                                                 Time: 08:30:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        1000 PPM                                                            
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60                                                               
  Scheduled Sacrifice                                 10           10                                                               
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
  Animals Examined Microscopically                    10           10                                                               
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (10)         (10)                                                             
      Basophilic Focus                                 4 (40%)                                                                      
      Hepatodiaphragmatic Nodule                                    3 (30%)                                                         
      Inflammation, Chronic                           10 (100%)    10 (100%)                                                        
      Centrilobular, Hypertrophy                                    2 (20%)                                                         
      Hepatocyte, Necrosis                                          3 (30%)                                                         
      Hepatocyte, Centrilobular, Hypertrophy                        6 (60%)                                                         
   Pancreas                                           (10)         (10)                                                             
      Acinus, Atrophy                                  1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   Heart                                              (10)         (10)                                                             
      Cardiomyopathy, Chronic                          2 (20%)      1 (10%)                                                         
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   Pituitary Gland                                    (10)         (10)                                                             
      Pars Distalis, Cyst                              1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Clitoral Gland                                     (10)         (10)                                                             
      Inflammation, Chronic Active                     6 (60%)      2 (20%)                                                         
   Ovary                                              (10)         (10)                                                             
      Cyst                                             1 (10%)      2 (20%)                                                         
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97  
Route: DOSED FEED                                                                                                 Time: 08:30:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        1000 PPM                                                            
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   Lung                                               (10)         (10)                                                             
      Inflammation, Chronic Active                     7 (70%)      5 (50%)                                                         
   Nose                                               (10)         (10)                                                             
      Inflammation, Chronic Active                     4 (40%)      1 (10%)                                                         
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                             (10)         (10)                                                             
      Mineralization                                  10 (100%)    10 (100%)                                                        
      Nephropathy, Chronic                             3 (30%)      3 (30%)                                                         
      Renal Tubule, Pigmentation                                   10 (100%)                                                        
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97  
Route: DOSED FEED                                                                                                 Time: 08:30:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        1000 PPM                                                            
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60                                                               
  Scheduled Sacrifice                                 10           10                                                               
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
  Animals Examined Microscopically                    10           10                                                               
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (10)         (10)                                                             
      Basophilic Focus                                 1 (10%)      1 (10%)                                                         
      Hepatodiaphragmatic Nodule                       1 (10%)                                                                      
      Inflammation, Chronic                            7 (70%)      5 (50%)                                                         
      Artery, Inflammation, Chronic                                 2 (20%)                                                         
      Bile Duct, Hyperplasia                                        2 (20%)                                                         
      Centrilobular, Hypertrophy                                    3 (30%)                                                         
      Hepatocyte, Hypertrophy                                       1 (10%)                                                         
      Hepatocyte, Vacuolization Cytoplasmic                         8 (80%)                                                         
      Hepatocyte, Centrilobular, Hypertrophy                        6 (60%)                                                         
   Pancreas                                           (10)         (10)                                                             
      Acinus, Atrophy                                  2 (20%)                                                                      
      Acinus, Inflammation, Chronic Active             2 (20%)                                                                      
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   Heart                                              (10)         (10)                                                             
      Cardiomyopathy, Chronic                          9 (90%)     10 (100%)                                                        
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   Pituitary Gland                                    (10)         (10)                                                             
      Pars Distalis, Hyperplasia                                    1 (10%)                                                         
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97  
Route: DOSED FEED                                                                                                 Time: 08:30:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        1000 PPM                                                            
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Epididymis                                         (10)         (10)                                                             
      Atrophy                                                       1 (10%)                                                         
      Inflammation, Chronic Active                                  1 (10%)                                                         
   Preputial Gland                                    (10)         (10)                                                             
      Inflammation, Chronic Active                    10 (100%)    10 (100%)                                                        
   Prostate                                           (10)         (10)                                                             
      Inflammation, Chronic Active                     5 (50%)      7 (70%)                                                         
   Testes                                             (10)         (10)                                                             
      Mineralization                                                1 (10%)                                                         
      Necrosis                                                      1 (10%)                                                         
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   Lung                                               (10)         (10)                                                             
      Inflammation, Chronic Active                     7 (70%)      6 (60%)                                                         
   Nose                                               (10)         (10)                                                             
      Fungus                                           1 (10%)      1 (10%)                                                         
      Inflammation, Chronic Active                     6 (60%)      1 (10%)                                                         
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 89002-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         PENTACHLOROPHENOL                                     Date: 10/28/97  
Route: DOSED FEED                                                                                                 Time: 08:30:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        1000 PPM                                                            
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                             (10)         (10)                                                             
      Mineralization                                   8 (80%)      9 (90%)                                                         
      Nephropathy, Chronic                            10 (100%)     9 (90%)                                                         
      Renal Tubule, Pigmentation                                   10 (100%)                                                        
      Transitional Epithelium, Hyperplasia                          1 (10%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------